# Biotique
Biotique is an Indian beauty and personal care brand making natural and ayurvedic products for skin, hair, make-up, and babies; it was founded in 1992 by Vinita Jain (विनीता जैन), is operated by parent company Bio Veda Action Research from Noida, Uttar Pradesh, remains privately held and debt-free, and is preparing an initial public offering intended to raise $300 million at a stated $3 billion valuation.[1](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms) • [2](https://www.brutimes.com/news/business/biotique-bridging-ancient-traditions-and-modern-skincare) It is a decades-old family business repositioning itself for public markets and digital channels rather than a venture-backed startup.[1](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms)
| Fact | Detail |
|---|---|
| Founded | 1992, by Vinita Jain[1](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms) |
| Headquarters | Noida, Uttar Pradesh, India[2](https://www.brutimes.com/news/business/biotique-bridging-ancient-traditions-and-modern-skincare) |
| Parent | Bio Veda Action Research, owned almost entirely by Jain[1](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms) |
| Sector | Beauty and personal care: natural and ayurvedic skin, hair, make-up, and baby products[1](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms) |
| External funding | None on record; internally funded and debt-free, with prior private equity approaches declined[1](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms) • [3](https://yourstory.com/2016/11/vinita-jain) |
| Planned IPO | $300 million raise, diluting 10%, at a stated $3 billion valuation[1](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms) |
| Status (September 2026) | Active, private, IPO in preparation; no DRHP filing confirmed in the sources[1](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms) |
## Founding and history
Vinita Jain started the business in 1992 with an initial investment of Rs 100 million (Rs 10 crore) and a team of six doctors, erecting Bio Veda Action Research as the company behind the brand.[3](https://yourstory.com/2016/11/vinita-jain) The company positioned Biotique as premium packaged, ayurvedic science-based beauty products, and its early strategy was export-led: with a factory in [Himachal Pradesh](https://www.edgepedia.org/himachal-pradesh) and an R&D facility in Switzerland, it began by retailing ayurvedic products in the Swiss market.[3](https://yourstory.com/2016/11/vinita-jain)
By 2016, in its 24th year, Biotique reported 15,000 points of sale, 4,000 multi-brand outlets, and exports to Switzerland, Spain, the US, France, the Netherlands, Italy, Malaysia, Nepal, Sri Lanka, Belgium, and Singapore, with a turnover of Rs 6 billion (Rs 600 crore); the founder stated 35% year-on-year growth and a valuation of over $1.5 billion.[3](https://yourstory.com/2016/11/vinita-jain) These 2016 figures are founder statements reported in a profile interview, not audited disclosures.
## Products, manufacturing and claims
According to the company's own account, Bio Veda Action Research began producing and selling Biotique health and beauty products in 1992, made of 100% organically grown, preservative-free botanical extracts of plants, herbs, trees, and the protein content in their roots, leaves, flowers, and fruits, cultivated, gathered, blended, and manufactured in the foothills of the [Himalayas](https://www.edgepedia.org/himalayas) and advanced by Swiss biotechnology.[4](https://www.biotique.com/pages/our-story) The company also states that its products involve no chemicals, no preservatives, no animal testing, eco-friendly recyclable packaging, and dermatologist testing for safety.[4](https://www.biotique.com/pages/our-story)
These statements are the company's own marketing claims.
## Funding and the IPO plan (by the numbers)
Biotique has taken no external funding on record. In a 2016 interview the founder described the company as internally funded and debt-free, calling that "a big achievement for an Indian player," and said it had declined external investor offers.[3](https://yourstory.com/2016/11/vinita-jain) [The Economic Times](https://www.edgepedia.org/the-economic-times) similarly reports that the company has previously resisted private equity stake-sale approaches.[1](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms)
The IPO plan marks a reversal of that stance. Founder and chairperson Vinita Jain said the company plans to dilute 10% equity in a public listing planned for the following year, raising $300 million at a stated valuation of $3 billion, and that the dilution is for the company's longevity.[1](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms) "We are in the process of consolidating and streamlining operations and group entities in preparation of our IPO. We are talking to three-four bankers including ICICI, Kotak, Motilal Oswal and IIFL for the process," Jain told ET.[1](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms)
IPO Central reports the proceeds are earmarked for three uses: research and development of new ayurvedic and plant-based formulations, domestic distribution expansion into Tier 2 and Tier 3 cities, and international growth in Asia, Europe, and the Middle East.[5](https://ipocentral.in/biotique-ipo-30-years-old-beauty-brand-to-go-public/) As of the latest reporting, the process stands at banker discussions and internal consolidation; the sources do not confirm that a draft red herring prospectus has been filed.
## Business and traction
The company's stated channel mix shows a fast-shifting distribution base. Jain said e-commerce sales grow at over 45% CAGR year-on-year, and quick commerce grows at 120% and contributes upwards of 15% of overall revenue.[1](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms) Biotique also supplies to over 200,000 hotel rooms daily.[1](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms)
In a January 2025 Davos interview, Jain said 2024 "has been fantastic; Biotique has grown over 30% year on year and the company is doing very well."[6](https://www.cnbctv18.com/business/davos-2025-how-biotique-is-using-technology-to-deliver-personalised-beauty-care-to-consumers-19544833.htm) All growth figures are company statements; no current absolute revenue figure is disclosed in the sources, the most recent being the 2016 turnover of Rs 6 billion (Rs 600 crore).[3](https://yourstory.com/2016/11/vinita-jain)
## Comparison with Indian beauty rivals
At a $3 billion valuation, Biotique would be on par with Nykaa and [Mamaearth](https://www.edgepedia.org/mamaearth), according to IPO Central, which frames the planned IPO as market recognition of India's ayurvedic beauty segment, where heritage brands and digital disruptors are competing for investor trust.[5](https://ipocentral.in/biotique-ipo-30-years-old-beauty-brand-to-go-public/) The contrast is structural: Biotique reached comparable scale over three decades as an internally funded family company.[1](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms) • [3](https://yourstory.com/2016/11/vinita-jain)
The market backdrop supports the timing. A Nykaa-Redseer report cited by ET estimates India's beauty and personal care market will touch $34 billion in sales by 2028, from $20 billion in 2024, growing at 10-11%.[1](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms)
## References
1. [Biotique looks to offload 10% stake via IPO next year - The Economic Times](https://economictimes.indiatimes.com/markets/ipos/fpos/biotique-looks-to-offload-10-stake-via-ipo-next-year/articleshow/124328045.cms)
2. [Biotique: Bridging Ancient Traditions and Modern Skincare - BruTimes](https://www.brutimes.com/news/business/biotique-bridging-ancient-traditions-and-modern-skincare)
3. [India's 'Beauty Queen': Biotique Founder Vinita Jain's story - YourStory](https://yourstory.com/2016/11/vinita-jain)
4. [Our Story - Biotique (company site)](https://www.biotique.com/pages/our-story)
5. [Biotique IPO: 30 Years Old Herbal Beauty Brand To Offload 10% Stake Next Year - IPO Central](https://ipocentral.in/biotique-ipo-30-years-old-beauty-brand-to-go-public/)
6. [How Biotique is using technology to deliver personalised beauty care to consumers - CNBC TV18](https://www.cnbctv18.com/business/davos-2025-how-biotique-is-using-technology-to-deliver-personalised-beauty-care-to-consumers-19544833.htm)
---
*Topic: Encyclopedia › Society and history › Economics and business › Business and work › Business and work overview › Companies and corporations › Venture-backed startups and growth companies › Fintech, commerce, and consumer startups › E-commerce marketplaces and retail › Titles symbols to K*
*Initially written Sep 17, 2026 · Reviewed: Sep 18, 2026 · Edited: Sep 18, 2026; Oct 11, 2026; Oct 15, 2026 · Last review: Sep 18, 2026*
*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*
License: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license